GL1X · GenesisL1 explorer

MolNFT v1 · #83756 · protein

Crystal structure of PDE10A in complex with a benzimidazole inhibitor

3WS8 · Camp and camp-inhibited cgmp 3',5'-cyclic phosphodiesterase…: “Crystal structure of PDE10A in complex with a benzimidazole inhibitor”. X-ray diffraction, 3 ligands (X4C, ZN, MG), 7 pockets (best druggability 0.74). MolNFT v1 #83756…

PDB
3WS8
Type
protein
Length
648 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Camp and camp-inhibited cgmp 3',5'-cyclic phosphodiesterase 10A
EC
3.1.4.17, 3.1.4.35
UniProt
Q9Y233
Ligands
X4C, ZN, MG
Pockets
7 · best druggability 0.74

Structure

x-ray diffraction · 1 distinct chain · 68% helix, 0% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, BCamp and camp-inhibited cgmp 3',5'-cyclic phosphodiesterase 10A (EC 3.1.4.17, 3.1.4.35)protein32468% helix, 0% strandQ9Y233

Ligands and binding sites

  • X4C · 8-methyl-6-[2-(5-methyl-1-phenyl-1H-benzimidazol-2-yl)ethyl]imidazo[1,5-a]pyrimidine · ligand · 2 copies · chains A, B
  • ZN · Zinc ion · metal · 2 copies · chains A, B
  • MG · Magnesium ion · metal · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

7 pockets found on a 1 Å grid, 3 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
16240.740.8159MG, X4C
27630.730.7869empty
34260.720.8247MG, X4C
41070.390.7623empty
5920.390.7722empty

Interfaces

1 interface between chains.

  • A–B · 839 Ų buried · 8 hydrogen bonds · protein-protein

Compared structures

  • 3WS8 · Crystal structure of PDE10A in complex with a benzimidazole inhibitor · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.